Lipid rafts, the sphingolipid and cholesterol-enriched membrane microdomains, are able to form different membrane macrodomains or platforms upon stimulations, including redox signaling platforms, which serve as a critical signaling mechanism to mediate or regulate cellular activities or functions. In particular, this raft platform formation provides an important driving force for the assembling of NADPH oxidase subunits and the recruitment of other related receptors, effectors, and regulatory components, resulting, in turn, in the activation of NADPH oxidase and downstream redox regulation of cell functions. This comprehensive review attempts to summarize all basic and advanced information about the formation, regulation, and functions of lipid raft redox signaling platforms as well as their physiological and pathophysiological relevance. Several molecular mechanisms involving the formation of lipid raft redox signaling platforms and the related therapeutic strategies targeting them are discussed. It is hoped that all information and thoughts included in this review could provide more comprehensive insights into the understanding of lipid raft redox signaling, in particular, of their molecular mechanisms, spatial-temporal regulations, and physiological, pathophysiological relevances to human health and diseases. Antioxid. Redox Signal. 15, 1043–1083.
AisenbreyC, BorowikT, BystromR, BokvistM, LindstromF, MisiakH, SaniMA, GrobnerG. How is protein aggregation in amyloidogenic diseases modulated by biological membranes?Eur Biophys J, 37:247–255. 2008.
7.
AliciaS, AngelicaZ, CarlosS, AlfonsoS, VacaL. STIM1 converts TRPC1 from a receptor-operated to a store-operated channel: moving TRPC1 in and out of lipid rafts. Cell Calcium, 44:479–491. 2008.
AmmonsMC, SiemsenDW, Nelson-OvertonLK, QuinnMT, GaussKA. Binding of pleomorphic adenoma gene-like 2 to the tumor necrosis factor (TNF)-alpha-responsive region of the NCF2 promoter regulates p67(phox) expression and NADPH oxidase activity. J Biol Chem, 282:17941–17952. 2007.
13.
AndersonRG, JacobsonK. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science, 296:1821–1825. 2002.
14.
AxelrodD. Total internal reflection fluorescence microscopy in cell biology. Traffic, 2:764–774. 2001.
15.
AyuyanAG, CohenFS. Lipid peroxides promote large rafts: effects of excitation of probes in fluorescence microscopy and electrochemical reactions during vesicle formation. Biophys J, 91:2172–2183. 2006.
16.
AzadMB, ChenY, GibsonSB. Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid Redox Signal, 11:777–790. 2009.
17.
AzadN, RojanasakulY, VallyathanV. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev, 11:1–15. 2008.
BaciaK, SchwilleP. A dynamic view of cellular processes by in vivo fluorescence auto- and cross-correlation spectroscopy. Methods, 29:74–85. 2003.
20.
BagiZ, FeherA, BeleznaiT. Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: implications for reactive oxygen species. Pharmacol Rep, 61:99–104. 2009.
21.
BagnatM, KeranenS, ShevchenkoA, SimonsK. Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc Natl Acad Sci U S A, 97:3254–3259. 2000.
22.
BainAJ, MarshRJ, ArmoogumDA, MonginO, PorresL, Blanchard-DesceM. Time-resolved stimulated emission depletion in two-photon excited states. Biochem Soc Trans, 31:1047–1051. 2003.
23.
BaintonDF. The discovery of lysosomes. J Cell Biol, 91:66s–76s. 1981.
24.
BanfiB, MalgrangeB, KniszJ, StegerK, Dubois-DauphinM, KrauseKH. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem, 279:46065–46072. 2004.
25.
BanfiB, TironeF, DurusselI, KniszJ, MoskwaP, MolnarGZ, KrauseKH, CoxJA. Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5)J Biol Chem, 279:18583–18591. 2004.
26.
BaoJX, JinS, ZhangF, WangZC, LiN, LiPL. Activation of membrane NADPH oxidase associated with lysosome-targeted acid sphingomyelinase in coronary endothelial cells. Antioxid Redox Signal, 12:703–712. 2010.
27.
BaoJX, XiaM, PoklisJL, HanWQ, BrimsonC, LiPL. Triggering role of acid sphingomyelinase in endothelial lysosome-membrane fusion and dysfunction in coronary arteries. Am J Physiol Heart Circ Physiol, 298:H992–H1002. 2010.
28.
BaranCP, ZeiglerMM, TridandapaniS, MarshCB. The role of ROS and RNS in regulating life and death of blood monocytes. Curr Pharm Des, 10:855–866. 2004.
29.
BatallerR, SchwabeRF, ChoiYH, YangL, PaikYH, LindquistJ, QianT, SchoonhovenR, HagedornCH, LemastersJJ, BrennerDA. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest, 112:1383–1394. 2003.
30.
BeckerKA, GellhausA, WinterhagerE, GulbinsE. Ceramide-enriched membrane domains in infectious biology and development. Subcell Biochem, 49:523–538. 2008.
31.
BedardK, KrauseKH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 87:245–313. 2007.
32.
BellEL, ChandelNS. Mitochondrial oxygen sensing: regulation of hypoxia-inducible factor by mitochondrial generated reactive oxygen species. Essays Biochem, 43:17–27. 2007.
33.
BiondaC, HadchityE, AlphonseG, ChapetO, RoussonR, Rodriguez-LafrasseC, ArdailD. Radioresistance of human carcinoma cells is correlated to a defect in raft membrane clustering. Free Radic Biol Med, 43:681–694. 2007.
34.
BismuthJ, LinP, YaoQ, ChenC. Ceramide: a common pathway for atherosclerosis?Atherosclerosis, 196:497–504. 2008.
35.
BlankU, CyprienB, Martin-VerdeauxS, PaumetF, PomboI, RiveraJ, RoaM, Varin-BlankN. SNAREs and associated regulators in the control of exocytosis in the RBL-2H3 mast cell line. Mol Immunol, 38:1341–1345. 2002.
36.
BlockK, GorinY, AbboudHE. Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci U S A, 106:14385–14390. 2009.
37.
BockerM, MuschterS, SchmittEK, SteinemC, SchafferTE. Imaging and patterning of pore-suspending membranes with scanning ion conductance microscopy. Langmuir, 25:3022–3028. 2009.
38.
BoiniKM, ZhangC, XiaM, PoklisJL, LiPL. Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet. J Pharmacol Exp Ther, 334:839–846. 2010.
BonifaceJJ, RabinowitzJD, WulfingC, HamplJ, ReichZ, AltmanJD, KantorRM, BeesonC, McConnellHM, DavisMM. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]Immunity, 9:459–466. 1998.
41.
BorregaardN, HeipleJM, SimonsER, ClarkRA. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol, 97:52–61. 1983.
42.
BowersWE. Christian de Duve and the discovery of lysosomes and peroxisomes. Trends Cell Biol, 8:330–333. 1998.
BrownDA, LondonE. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol, 14:111–136. 1998.
46.
BrownDA, LondonE. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem, 275:17221–17224. 2000.
47.
BrownDA, RoseJK. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell, 68:533–544. 1992.
48.
BrownDI, GriendlingKK. Nox proteins in signal transduction. Free Radic Biol Med, 47:1239–1253. 2009.
49.
BryantMR, MartaCB, KimFS, BansalR. Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes. Glia, 57:935–946. 2009.
50.
BurdonRH. Control of cell proliferation by reactive oxygen species. Biochem Soc Trans, 24:1028–1032. 1996.
51.
CaiH. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res, 96:818–822. 2005.
52.
CaiH. A new mechanism for flow-mediated vasoprotection? Focus on “lung endothelial cell proliferation with decreased shear stress is mediated by reactive oxygen species.”Am J Physiol Cell Physiol, 290:C35–C36. 2006.
53.
CanevariL, ClarkJB. Alzheimer's disease and cholesterol: the fat connection. Neurochem Res, 32:739–750. 2007.
54.
CaroniP. New EMBO members' review: actin cytoskeleton regulation through modulation of PI(4,5)P(2) rafts. EMBO J, 20:4332–4336. 2001.
55.
CasadesusG, SmithMA, ZhuX, AlievG, CashAD, HondaK, PetersenRB, PerryG. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. J Alzheimers Dis, 6:165–169. 2004.
56.
ChatterjeeM, WuS. Cell line dependent involvement of ceramide in ultraviolet light-induced apoptosis. Mol Cell Biochem, 219:21–27. 2001.
57.
ChengG, CaoZ, XuX, van MeirEG, LambethJD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene, 269:131–140. 2001.
58.
ChengH, VetrivelKS, GongP, MecklerX, ParentA, ThinakaranG. Mechanisms of disease: new therapeutic strategies for Alzheimer's disease—targeting APP processing in lipid rafts. Nat Clin Pract Neurol, 3:374–382. 2007.
59.
ChengPC, DykstraML, MitchellRN, PierceSK. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med, 190:1549–1560. 1999.
60.
ChengZJ, SinghRD, MarksDL, PaganoRE. Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids. Mol Membr Biol, 23:101–110. 2006.
61.
ChiniB, ParentiM. G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats. J Mol Endocrinol, 42:371–379. 2009.
62.
ChiniEN, BeersKW, DousaTP. Nicotinate adenine dinucleotide phosphate (NAADP) triggers a specific calcium release system in sea urchin eggs. J Biol Chem, 270:3216–3223. 1995.
63.
CiarloL, ManganelliV, GarofaloT, MatarreseP, TinariA, MisasiR, MalorniW, SoriceM. Association of fission proteins with mitochondrial raft-like domains. Cell Death Differ, 17:1047–1058. 2010.
64.
ClempusRE, GriendlingKK. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res, 71:216–225. 2006.
65.
ColavittiR, FinkelT. Reactive oxygen species as mediators of cellular senescence. IUBMB Life, 57:277–281. 2005.
CordyJM, HooperNM, TurnerAJ. The involvement of lipid rafts in Alzheimer's disease. Mol Membr Biol, 23:111–122. 2006.
68.
CremestiAE, GoniFM, KolesnickR. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome?FEBS Lett, 531:47–53. 2002.
69.
CutlerRG, MattsonMP. Sphingomyelin and ceramide as regulators of development and lifespan. Mech Ageing Dev, 122:895–908. 2001.
70.
DangPM, CrossAR, QuinnMT, BabiorBM. Assembly of the neutrophil respiratory burst oxidase: a direct interaction between p67PHOX and cytochrome b558 II. Proc Natl Acad Sci U S A, 99:4262–4265. 2002.
71.
de HaasM, VossebeldPJ, von dem BorneAE, RoosD. Fc gamma receptors of phagocytes. J Lab Clin Med, 126:330–341. 1995.
72.
Del PreteA, ZaccagninoP, Di PaolaM, SaltarellaM, Oliveros CelisC, NicoB, SantoroG, LorussoM. Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions. Free Radic Biol Med, 44:1443–1451. 2008.
73.
DellesC, MillerWH, DominiczakAF. Targeting reactive oxygen species in hypertension. Antioxid Redox Signal, 10:1061–1077. 2008.
74.
DesplanquesAS, NauwynckHJ, TillemanK, DeforceD, FavoreelHW. Tyrosine phosphorylation and lipid raft association of pseudorabies virus glycoprotein E during antibody-mediated capping. Virology, 362:60–66. 2007.
75.
Di VizioD, SolomonKR, FreemanMR. Cholesterol and cholesterol-rich membranes in prostate cancer: an update. Tumori, 94:633–639. 2008.
76.
DikalovaAE, GongoraMC, HarrisonDG, LambethJD, DikalovS, GriendlingKK. Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via enos uncoupling. Am J Physiol Heart Circ Physiol, 299:H673–H679. 2010.
77.
DonatiRJ, RasenickMM. Chronic antidepressant treatment prevents accumulation of gsalpha in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts)Neuropsychopharmacology, 30:1238–1245. 2005.
78.
DowneyGP, FukushimaT, FialkowL. Signaling mechanisms in human neutrophils. Curr Opin Hematol, 2:76–88. 1995.
79.
DraperJM, XiaZ, SmithCD. Cellular palmitoylation and trafficking of lipidated peptides. J Lipid Res, 48:1873–1884. 2007.
80.
DreminaES, SharovVS, SchoneichC. Protein tyrosine nitration in rat brain is associated with raft proteins, flotillin-1 and alpha-tubulin: effect of biological aging. J Neurochem, 93:1262–1271. 2005.
81.
DumitruCA, ZhangY, LiX, GulbinsE. Ceramide: a novel player in reactive oxygen species-induced signaling?Antioxid Redox Signal, 9:1535–1540. 2007.
EggelingC, RingemannC, MeddaR, SchwarzmannG, SandhoffK, PolyakovaS, BelovVN, HeinB, von MiddendorffC, SchonleA, HellSW. Direct observation of the nanoscale dynamics of membrane lipids in a living cell. Nature, 457:1159–1162. 2009.
84.
EidAA, GorinY, FaggBM, MaaloufR, BarnesJL, BlockK, AbboudHE. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes, 58:1201–1211. 2009.
85.
El-BennaJ, DangPM, Gougerot-PocidaloMA. Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin Immunopathol, 30:279–289. 2008.
86.
El KiratK, MorandatS, DufreneYF. Nanoscale analysis of supported lipid bilayers using atomic force microscopy. Biochim Biophys Acta, 1798:750–765. 2010.
87.
EsenM, SchreinerB, JendrossekV, LangF, FassbenderK, GrassmeH, GulbinsE. Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis, 6:431–439. 2001.
88.
EumSY, AndrasI, HennigB, ToborekM. NADPH oxidase and lipid raft-associated redox signaling are required for PCB153-induced upregulation of cell adhesion molecules in human brain endothelial cells. Toxicol Appl Pharmacol, 240:299–305. 2009.
89.
Fallahi-SichaniM, LindermanJJ. Lipid raft-mediated regulation of G-protein coupled receptor signaling by ligands which influence receptor dimerization: a computational study. PLoS One, 4:e6604. 2009.
90.
Feuk-LagerstedtE, MovitzC, PellmeS, DahlgrenC, KarlssonA. Lipid raft proteome of the human neutrophil azurophil granule. Proteomics, 7:194–205. 2007.
91.
FinkelT, HolbrookNJ. Oxidants, oxidative stress and the biology of ageing. Nature, 408:239–247. 2000.
92.
FischerH. Mechanisms and function of DUOX in epithelia of the lung. Antioxid Redox Signal, 11:2453–2465. 2009.
FosterJD, AdkinsSD, LeverJR, VaughanRA. Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J Neurochem, 105:1683–1699. 2008.
98.
FosterLJ, De HoogCL, MannM. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci U S A, 100:5813–5818. 2003.
FreyRS, RahmanA, KeferJC, MinshallRD, MalikAB. PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res, 90:1012–1019. 2002.
101.
FriedrichsonT, KurzchaliaTV. Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature, 394:802–805. 1998.
102.
FubiniB, HubbardA. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med, 34:1507–1516. 2003.
103.
FuhlerGM, BlomNR, CofferPJ, DrayerAL, VellengaE. The reduced GM-CSF priming of ROS production in granulocytes from patients with myelodysplasia is associated with an impaired lipid raft formation. J Leukoc Biol, 81:449–457. 2007.
104.
FujimotoS, SatohM, HorikeH, HattaH, HarunaY, KobayashiS, NamikoshiT, ArakawaS, TomitaN, KashiharaN. Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production. Hypertens Res, 31:305–313. 2008.
105.
FujimuraY, TachibanaH, YamadaK. Lipid raft-associated catechin suppresses the FcepsilonRI expression by inhibiting phosphorylation of the extracellular signal-regulated kinase1/2. FEBS Lett, 556:204–210. 2004.
FultonDJ. Nox5 and the regulation of cellular function. Antioxid Redox Signal, 11:2443–2452. 2009.
108.
GalanC, WoodardGE, DionisioN, SalidoGM, RosadoJA. Lipid rafts modulate the activation but not the maintenance of store-operated Ca(2+) entry. Biochim Biophys Acta, 1803:1083–1093. 2010.
109.
GalliF. Membrane rafts and redox therapies in cancer: a commentary on Radioresistance of human carcinoma cells is correlated to a defect in raft membrane clustering. Free Radic Biol Med, 43:678–680. 2007.
110.
GamaleiIA, EfremovaTN, KirpichnikovaKM, KomissarchikYY, KeverLV, PolozovYV, KhaitlinaSY. Decreased sensitivity of transformed 3T3-SV40 cells treated with N-acetylcysteine to bacterial invasion. Bull Exp Biol Med, 142:90–93. 2006.
111.
GambaraG, BillingtonRA, DebiddaM, D'AlessioA, PalombiF, ZiparoE, GenazzaniAA, FilippiniA. NAADP-induced Ca(2+ signaling in response to endothelin is via the receptor subtype B and requires the integrity of lipid rafts/caveolae. J Cell Physiol, 216:396–404. 2008.
112.
Garcia-CardenaG, OhP, LiuJ, SchnitzerJE, SessaWC. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci U S A, 93:6448–6453. 1996.
113.
GarciaRC, SegalAW. Changes in the subcellular distribution of the cytochrome b-245 on stimulation of human neutrophils. Biochem J, 219:233–242. 1984.
114.
GaussKA, Nelson-OvertonLK, SiemsenDW, GaoY, DeLeoFR, QuinnMT. Role of NF-kappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha. J Leukoc Biol, 82:729–741. 2007.
115.
GeisztM, KoppJB, VarnaiP, LetoTL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A, 97:8010–8014. 2000.
116.
GendzwillA. [Reactive oxygen species and vascular hyporeactivity in septic shock. Part I—reactive oxygen species and vascular hyporeactivity]Pol Merkur Lekarski, 23:280–283. 2007.
117.
GendzwillA. [Reactive oxygen species and vascular hyporeactivity in septic shock. Part II—scavengers and vascular hyporeactivity in septic shock]Pol Merkur Lekarski, 23:284–287. 2007.
118.
GerstJE. SNAREs and SNARE regulators in membrane fusion and exocytosis. Cell Mol Life Sci, 55:707–734. 1999.
119.
GoligorskyMS, LiH, BrodskyS, ChenJ. Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am J Physiol Renal Physiol, 283:F1–F10. 2002.
120.
GongXM, FranzinCM, ThaiK, YuJ, MarassiFM. Nuclear magnetic resonance structural studies of membrane proteins in micelles and bilayers. Methods Mol Biol, 400:515–529. 2007.
121.
GongoraMC, LobHE, LandmesserU, GuzikTJ, MartinWD, OzumiK, WallSM, WilsonDS, MurthyN, GravanisM, FukaiT, HarrisonDG. Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome. Am J Pathol, 173:915–926. 2008.
122.
GoniFM, AlonsoA. Sphingomyelinases: enzymology and membrane activity. FEBS Lett, 531:38–46. 2002.
123.
GorinY, BlockK, HernandezJ, BhandariB, WagnerB, BarnesJL, AbboudHE. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem, 280:39616–39626. 2005.
124.
GorlachA, BrandesRP, NguyenK, AmidiM, DehghaniF, BusseR. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res, 87:26–32. 2000.
125.
GoswamiD, GowrishankarK, BilgramiS, GhoshS, RaghupathyR, ChaddaR, VishwakarmaR, RaoM, MayorS. Nanoclusters of GPI-anchored proteins are formed by cortical actin-driven activity. Cell, 135:1085–1097. 2008.
126.
GoswamiSK, MaulikN, DasDK. Ischemia-reperfusion and cardioprotection: a delicate balance between reactive oxygen species generation and redox homeostasis. Ann Med, 39:275–289. 2007.
GrassmeH, RiehleA, WilkerB, GulbinsE. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J Biol Chem, 280:26256–26262. 2005.
135.
GreavesJ, ChamberlainLH. Palmitoylation-dependent protein sorting. J Cell Biol, 176:249–254. 2007.
136.
GriendlingKK. Novel NAD(P)H oxidases in the cardiovascular system. Heart, 90:491–493. 2004.
137.
GriendlingKK, MinieriCA, OllerenshawJD, AlexanderRW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res, 74:1141–1148. 1994.
138.
GriendlingKK, SorescuD, Ushio-FukaiM. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res, 86:494–501. 2000.
139.
GriffithsG. Cell evolution and the problem of membrane topology. Nat Rev Mol Cell Biol, 8:1018–1024. 2007.
140.
GroempingY, LapougeK, SmerdonSJ, RittingerK. Molecular basis of phosphorylation-induced activation of the NADPH oxidase. Cell, 113:343–355. 2003.
141.
GrossO, PoeckH, BscheiderM, DostertC, HannesschlagerN, EndresS, HartmannG, TardivelA, SchweighofferE, TybulewiczV, MocsaiA, TschoppJ, RulandJ. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature, 459:433–436. 2009.
142.
GuichardC, PedruzziE, FayM, Ben MkaddemS, CoantN, DanielF, Ogier-DenisE. [The Nox/Duox family of ROS-generating NADPH oxidases]Med Sci (Paris), 22:953–959. 2006.
143.
GulbinsE. Highlight: sphingolipids—signals and disease. Biol Chem, 389:1347–1348. 2008.
144.
GulbinsE, GrassmeH. Ceramide and cell death receptor clustering. Biochim Biophys Acta, 1585:139–145. 2002.
145.
GulbinsE, KolesnickR. Raft ceramide in molecular medicine. Oncogene, 22:7070–7077. 2003.
146.
GulbinsE, LiPL. Physiological and pathophysiological aspects of ceramide. Am J Physiol Regul Integr Comp Physiol, 290:R11–R26. 2006.
147.
GupteSA, WolinMS. Oxidant and redox signaling in vascular oxygen sensing: implications for systemic and pulmonary hypertension. Antioxid Redox Signal, 10:1137–1152. 2008.
148.
GuzyRD, SchumackerPT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol, 91:807–819. 2006.
149.
HalliwellB, CrossCE. Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect, 102,Suppl 10:5–12. 1994.
150.
HanW, LiH, VillarVA, PascuaAM, DajaniMI, WangX, NatarajanA, QuinnMT, FelderRA, JosePA, YuP. Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension, 51:481–487. 2008.
151.
HancockJF. Lipid rafts: contentious only from simplistic standpoints. Nat Rev Mol Cell Biol, 7:456–462. 2006.
152.
HannunYA, BellRM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science, 243:500–507. 1989.
153.
HansbergW, de GrootH, SiesH. Reactive oxygen species associated with cell differentiation in Neurospora crassa. Free Radic Biol Med, 14:287–293. 1993.
154.
HansenCG, NicholsBJ. Exploring the caves: cavins, caveolins and caveolae. Trends Cell Biol, 20:177–186. 2010.
155.
HansenGH, Niels-ChristiansenLL, ThorsenE, ImmerdalL, DanielsenEM. Cholesterol depletion of enterocytes. Effect on the Golgi complex and apical membrane trafficking. J Biol Chem, 275:5136–5142. 2000.
156.
HaraT, KondoN, NakamuraH, OkuyamaH, MitsuiA, HoshinoY, YodoiJ. Cell-surface thioredoxin-1: possible involvement in thiol-mediated leukocyte-endothelial cell interaction through lipid rafts. Antioxid Redox Signal, 9:1427–1437. 2007.
157.
HarderT, SimonsK. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr Opin Cell Biol, 9:534–542. 1997.
158.
HauckCR, GrassmeH, BockJ, JendrossekV, FerlinzK, MeyerTF, GulbinsE. Acid sphingomyelinase is involved in CEACAM receptor-mediated phagocytosis of Neisseria gonorrhoeae. FEBS Lett, 478:260–266. 2000.
HelmsJB, ZurzoloC. Lipids as targeting signals: lipid rafts and intracellular trafficking. Traffic, 5:247–254. 2004.
161.
HessST, GouldTJ, GudhetiMV, MaasSA, MillsKD, ZimmerbergJ. Dynamic clustered distribution of hemagglutinin resolved at 40 nm in living cell membranes discriminates between raft theories. Proc Natl Acad Sci U S A, 104:17370–17375. 2007.
162.
HildemanDA. Regulation of T-cell apoptosis by reactive oxygen species. Free Radic Biol Med, 36:1496–1504. 2004.
163.
HilenskiLL, ClempusRE, QuinnMT, LambethJD, GriendlingKK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 24:677–683. 2004.
164.
HillJM, SteinerI, MatthewsKE, TrahanSG, FosterTP, BallMJ. Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of Herpes simplex virus type 1. Med Hypotheses, 64:53–58. 2005.
165.
HillyardDZ, JardineAG, McDonaldKJ, CameronAJ. Fluvastatin inhibits raft dependent Fcgamma receptor signalling in human monocytes. Atherosclerosis, 172:219–228. 2004.
166.
HillyardDZ, NuttCD, ThomsonJ, McDonaldKJ, WanRK, CameronAJ, MarkPB, JardineAG. Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation. Atherosclerosis, 191:319–325. 2007.
167.
HirookaY. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton Neurosci, 142:20–24. 2008.
168.
HoekstraD, MaierO, van der WoudenJM, SlimaneTA, vanISC. Membrane dynamics and cell polarity: the role of sphingolipids. J Lipid Res, 44:869–77. 2003.
169.
HolowkaD, SheetsED, BairdB. Interactions between Fc(epsilon)RI and lipid raft components are regulated by the actin cytoskeleton. J Cell Sci, 113,Pt 6:1009–1019. 2000.
170.
HolzRW, AxelrodD. Secretory granule behaviour adjacent to the plasma membrane before and during exocytosis: total internal reflection fluorescence microscopy studies. Acta Physiol (Oxf), 192:303–307. 2008.
171.
HuJ, JiaS, LiP. Statins Block the Formation of Lipid Raft Redox Signaling Platforms in Coronary Endothelial Cells. FASEB J, 23. 2009.
172.
HungYH, RobbEL, VolitakisI, HoM, EvinG, LiQX, CulvenorJG, MastersCL, ChernyRA, BushAI. Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease. J Biol Chem, 284:21899–21907. 2009.
173.
HuynhC, RothD, WardDM, KaplanJ, AndrewsNW. Defective lysosomal exocytosis and plasma membrane repair in Chediak-Higashi/beige cells. Proc Natl Acad Sci U S A, 101:16795–16800. 2004.
IkonenE, VainioS. Lipid microdomains and insulin resistance: is there a connection?Sci STKE, 2005:pe3. 2005.
178.
InokuchiJ. Insulin resistance as a membrane microdomain disorder. Biol Pharm Bull, 29:1532–1537. 2006.
179.
InselPA, HeadBP, OstromRS, PatelHH, SwaneyJS, TangCM, RothDM. Caveolae and lipid rafts: G protein-coupled receptor signaling microdomains in cardiac myocytes. Ann N Y Acad Sci, 1047:166–172. 2005.
180.
IsraelachviliJN. Refinement of the fluid-mosaic model of membrane structure. Biochim Biophys Acta, 469:221–225. 1977.
181.
JainMK, WhiteHB3rd. Long-range order in biomembranes. Adv Lipid Res, 15:1–60. 1977.
182.
JaiswalJK, AndrewsNW, SimonSM. Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J Cell Biol, 159:625–635. 2002.
183.
JaksitsS, BauerW, KriehuberE, ZeydaM, StulnigTM, StinglG, FiebigerE, MaurerD. Lipid raft-associated GTPase signaling controls morphology and CD8+ T cell stimulatory capacity of human dendritic cells. J Immunol, 173:1628–1639. 2004.
JanJT, ChatterjeeS, GriffinDE. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol, 74:6425–6432. 2000.
186.
JanaA, PahanK. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J Biol Chem, 279:51451–51459. 2004.
187.
JardinI, SalidoGM, RosadoJA. Role of lipid rafts in the interaction between hTRPC1, Orai1 and STIM1. Channels (Austin), 2:401–403. 2008.
188.
JiaSJ, JinS, ZhangF, YiF, DeweyWL, LiPL. Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes. Am J Physiol Heart Circ Physiol, 295:H1743–H1752. 2008.
189.
JinS, YiF, LiPL. Contribution of lysosomal vesicles to the formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal, 9:1417–1426. 2007.
190.
JinS, YiF, ZhangF, PoklisJL, LiPL. Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells. Arterioscler Thromb Vasc Biol, 28:2056–2062. 2008.
191.
JinS, ZhangY, YiF, LiPL. Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol, 28:485–490. 2008.
192.
JinS, ZhouF. Lipid raft redox signaling platforms in vascular dysfunction: features and mechanisms. Curr Atheroscler Rep, 11:220–226. 2009.
193.
JinZX, HuangCR, DongL, GodaS, KawanamiT, SawakiT, SakaiT, TongXP, MasakiY, FukushimaT, TanakaM, MimoriT, TojoH, BloomET, OkazakiT, UmeharaH. Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells. Int Immunol, 20:1427–1437. 2008.
194.
JosePA, EisnerGM, FelderRA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens, 11:87–92. 2002.
KaushalGP, SinghAB, ShahSV. Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am J Physiol, 274:F587–F595. 1998.
197.
KawabeJ, OkumuraS, NathansonMA, HasebeN, IshikawaY. Caveolin regulates microtubule polymerization in the vascular smooth muscle cells. Biochem Biophys Res Commun, 342:164–169. 2006.
198.
KenworthyAK, PetranovaN, EdidinM. High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol Biol Cell, 11:1645–1655. 2000.
199.
KhanN, SwartzH. Measurements in vivo of parameters pertinent to ROS/RNS using EPR spectroscopy. Mol Cell Biochem, 234–235341–3572002.
200.
KietzmannT, GorlachA. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol, 16:474–486. 2005.
KinnearNP, BoittinFX, ThomasJM, GalioneA, EvansAM. Lysosome-sarcoplasmic reticulum junctions. A trigger zone for calcium signaling by nicotinic acid adenine dinucleotide phosphate and endothelin-1. J Biol Chem, 279:54319–54326. 2004.
203.
KinoshitaA, FukumotoH, ShahT, WhelanCM, IrizarryMC, HymanBT. Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J Cell Sci, 116:3339–3346. 2003.
204.
KirkhamM, PartonRG. Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim Biophys Acta, 1746:349–363. 2005.
205.
KirkhamM, PartonRG. Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim Biophys Acta, 1745:273–286. 2005.
206.
KissAL, BotosE. Endocytosis via caveolae: alternative pathway with distinct cellular compartments to avoid lysosomal degradation?J Cell Mol Med, 13:1228–1237. 2009.
207.
KitataniK, Idkowiak-BaldysJ, HannunYA. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal, 20:1010–1018. 2008.
208.
KojdaG, HarrisonD. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res, 43:562–571. 1999.
209.
KolzerM, ArenzC, FerlinzK, WerthN, SchulzeH, KlingensteinR, SandhoffK. Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase. Biol Chem, 384:1293–1298. 2003.
KonoH, SuzukiT, YamamotoK, OkadaM, YamamotoT, HondaZ. Spatial raft coalescence represents an initial step in Fc gamma R signaling. J Immunol, 169:193–203. 2002.
212.
KornED. Structure and function of the plasma membrane. A biochemical perspective. J Gen Physiol, 52:257–278. 1968.
213.
KornhuberJ, ReichelM, TripalP, GroemerTW, HenkelAW, MuhleC, GulbinsE. The role of ceramide in major depressive disorder. Eur Arch Psychiatry Clin Neurosci, 259,Suppl 2:S199–S204. 2009.
214.
KornhuberJ, TripalP, ReichelM, MuhleC, RheinC, MuehlbacherM, GroemerTW, GulbinsE. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem, 26:9–20. 2010.
215.
KornhuberJ, TripalP, ReichelM, TerflothL, BleichS, WiltfangJ, GulbinsE. Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. J Med Chem, 51:219–237. 2008.
216.
KosugiA, SakakuraJ, YasudaK, OgataM, HamaokaT. Involvement of SHP-1 tyrosine phosphatase in TCR-mediated signaling pathways in lipid rafts. Immunity, 14:669–680. 2001.
217.
KsiazekK, WisniewskaJ. [The role of glucose and reactive oxygen species in the development of vascular complications of diabetes mellitus]Przegl Lek, 58:915–918. 2001.
218.
KulmaM, HerecM, GrudzinskiW, AnderluhG, GruszeckiWI, KwiatkowskaK, SobotaA. Sphingomyelin-rich domains are sites of lysenin oligomerization: implications for raft studies. Biochim Biophys Acta, 1798:471–481. 2010.
219.
KusmartsevS, GabrilovichDI. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. J Leukoc Biol, 74:186–196. 2003.
220.
LambethJD. Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr Opin Hematol, 9:11–17. 2002.
221.
LangF, GulbinsE, LangPA, ZappullaD, FollerM. Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem, 26:21–28. 2010.
222.
LangF, LangKS, LangPA, HuberSM, WiederT. Mechanisms and significance of eryptosis. Antioxid Redox Signal, 8:1183–1192. 2006.
223.
LassegueB, ClempusRE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol, 285:R277–R297. 2003.
224.
LauxT, FukamiK, ThelenM, GolubT, FreyD, CaroniP. GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J Cell Biol, 149:1455–1472. 2000.
225.
LawrenceDS, ZilfouJT, SmithCD. Structure-activity studies of cerulenin analogues as protein palmitoylation inhibitors. J Med Chem, 42:4932–4941. 1999.
LefebvreB, FurtF, HartmannMA, MichaelsonLV, CardeJP, Sargueil-BoironF, RossignolM, NapierJA, CullimoreJ, BessouleJJ, MongrandS. Characterization of lipid rafts from Medicago truncatula root plasma membranes: a proteomic study reveals the presence of a raft-associated redox system. Plant Physiol, 144:402–418. 2007.
228.
LeglerDF, MicheauO, DouceyMA, TschoppJ, BronC. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity, 18:655–664. 2003.
229.
LennePF, WawrezinieckL, ConchonaudF, WurtzO, BonedA, GuoXJ, RigneaultH, HeHT, MarguetD. Dynamic molecular confinement in the plasma membrane by microdomains and the cytoskeleton meshwork. EMBO J, 25:3245–3256. 2006.
230.
LevitanI, GoochKJ. Lipid rafts in membrane-cytoskeleton interactions and control of cellular biomechanics: actions of oxLDL. Antioxid Redox Signal, 9:1519–1534. 2007.
LiX, BeckerKA, ZhangY. Ceramide in redox signaling and cardiovascular diseases. Cell Physiol Biochem, 26:41–48. 2010.
237.
LinCF, ChenCL, LinYS. Ceramide in apoptotic signaling and anticancer therapy. Curr Med Chem, 13:1609–1616. 2006.
238.
LinWC, BlanchetteCD, RattoTV, LongoML. Lipid domains in supported lipid bilayer for atomic force microscopy. Methods Mol Biol, 400:503–513. 2007.
239.
LinderME, DeschenesRJ. Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol, 8:74–84. 2007.
240.
LingwoodD, KaiserHJ, LeventalI, SimonsK. Lipid rafts as functional heterogeneity in cell membranes. Biochem Soc Trans, 37:955–960. 2009.
241.
LingwoodD, SimonsK. Lipid rafts as a membrane-organizing principle. Science, 327:46–50. 2010.
242.
LiuCY, LeeCF, WeiYH. Role of reactive oxygen species-elicited apoptosis in the pathophysiology of mitochondrial and neurodegenerative diseases associated with mitochondrial DNA mutations. J Formos Med Assoc, 108:599–611. 2009.
243.
LotockiG, AlonsoOF, DietrichWD, KeaneRW. Tumor necrosis factor receptor 1 and its signaling intermediates are recruited to lipid rafts in the traumatized brain. J Neurosci, 24:11010–11016. 2004.
244.
LuSP, Lin FengMH, HuangHL, HuangYC, TsouWI, LaiMZ. Reactive oxygen species promote raft formation in T lymphocytes. Free Radic Biol Med, 42:936–944. 2007.
245.
MacFarlanePM, WilkersonJE, Lovett-BarrMR, MitchellGS. Reactive oxygen species and respiratory plasticity following intermittent hypoxia. Respir Physiol Neurobiol, 164:263–271. 2008.
246.
MackeyAM, SanvicensN, GroegerG, DoonanF, WallaceD, CotterTG. Redox survival signalling in retina-derived 661W cells. Cell Death Differ, 15:1291–1303. 2008.
247.
MageeAI, ParmrydI. Detergent-resistant membranes and the protein composition of lipid rafts. Genome Biol, 4:234. 2003.
248.
MahammadS, ParmrydI. Cholesterol homeostasis in T cells. Methyl-beta-cyclodextrin treatment results in equal loss of cholesterol from Triton X-100 soluble and insoluble fractions. Biochim Biophys Acta, 1778:1251–1258. 2008.
MartynKD, FrederickLM, von LoehneysenK, DinauerMC, KnausUG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal, 18:69–82. 2006.
252.
MashimoM, NishikawaM, HiguchiK, HiroseM, WeiQ, HaqueA, SasakiE, ShibaM, TominagaK, WatanabeT, FujiwaraY, ArakawaT, InoueM. Production of reactive oxygen species in peripheral blood is increased in individuals with Helicobacter pylori infection and decreased after its eradication. Helicobacter, 11:266–271. 2006.
253.
Mas-OlivaJ, Delgado-CoelloB. Protein stability and the evolution of the cell membrane. Comp Biochem Physiol C Toxicol Pharmacol, 146:207–213. 2007.
254.
MatesJM, Sanchez-JimenezFM. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol, 32:157–170. 2000.
255.
MathiasS, KolesnickR. Ceramide: a novel second messenger. Adv Lipid Res, 25:65–90. 1993.
256.
MattjusP, SlotteJP. Does cholesterol discriminate between sphingomyelin and phosphatidylcholine in mixed monolayers containing both phospholipids?Chem Phys Lipids, 81:69–80. 1996.
257.
McNeilPL, KirchhausenT. An emergency response team for membrane repair. Nat Rev Mol Cell Biol, 6:499–505. 2005.
258.
MikuniS, KinjoM. [Fluorescence correlation spectroscopy and fluorescence cross correlation spectroscopy for cell biology]Tanpakushitsu Kakusan Koso, 51:1998–2005. 2006.
259.
MohazzabKM, KaminskiPM, WolinMS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol, 266:H2568–H2572. 1994.
MukherjeaD, JajooS, KaurT, SheehanKE, RamkumarV, RybakLP. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Antioxid Redox Signal, 13:589–598. 2010.
262.
MukherjeeSP, LaneRH, LynnWS. Endogenous hydrogen peroxide and peroxidative metabolism in adipocytes in response to insulin and sulfhydryl reagents. Biochem Pharmacol, 27:2589–2594. 1978.
263.
MukherjeeSP, LynnWS. Reduced nicotinamide adenine dinucleotide phosphate oxidase in adipocyte plasma membrane and its activation by insulin. Possible role in the hormone's effects on adenylate cyclase and the hexose monophosphate shunt. Arch Biochem Biophys, 184:69–76. 1977.
264.
Muller-PeddinghausR. [Reactive oxygen species and inflammation]Dtsch Tierarztl Wochenschr, 96:210–212. 1989.
MunroS. Lipid rafts: elusive or illusive?Cell, 115:377–388. 2003.
267.
MurataT, LinMI, HuangY, YuJ, BauerPM, GiordanoFJ, SessaWC. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med, 204:2373–2382. 2007.
268.
MurateT, SuzukiM, HattoriM, TakagiA, KojimaT, TanizawaT, AsanoH, HottaT, SaitoH, YoshidaS, Tamiya-KoizumiK. Up-regulation of acid sphingomyelinase during retinoic acid-induced myeloid differentiation of NB4, a human acute promyelocytic leukemia cell line. J Biol Chem, 277:9936–9943. 2002.
NadaS, HondoA, KasaiA, KoikeM, SaitoK, UchiyamaY, OkadaM. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes. EMBO J, 28:477–489. 2009.
271.
NeblT, PestonjamaspKN, LeszykJD, CrowleyJL, OhSW, LunaEJ. Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. J Biol Chem, 277:43399–43409. 2002.
272.
NgG, ChauEMT, ShiY. Recent developments in immune activation by uric acid crystals. Archivum Immunologiae Et Therapiae Experimentalis, 58:273–277. 2010.
273.
NgG, SharmaK, WardSM, DesrosiersMD, StephensLA, SchoelWM, LiT, LowellCA, LingCC, AmreinMW, ShiY. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity, 29:807–818. 2008.
274.
NiX, MoralesCR. The lysosomal trafficking of acid sphingomyelinase is mediated by sortilin and mannose 6-phosphate receptor. Traffic, 7:889–902. 2006.
275.
NiccoC, LaurentA, ChereauC, WeillB, BatteuxF. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother, 59:169–174. 2005.
276.
NicholsBJ. A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex. Nat Cell Biol, 4:374–378. 2002.
277.
NicolauDVJr., BurrageK, PartonRG, HancockJF. Identifying optimal lipid raft characteristics required to promote nanoscale protein-protein interactions on the plasma membrane. Mol Cell Biol, 26:313–323. 2006.
278.
NieminenJ, KunoA, HirabayashiJ, SatoS. Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer. J Biol Chem, 282:1374–1383. 2007.
279.
NikaK, CharvetC, WilliamsS, TautzL, BrucknerS, RahmouniS, BottiniN, SchoenbergerSP, BaierG, AltmanA, MustelinT. Lipid raft targeting of hematopoietic protein tyrosine phosphatase by protein kinase C theta-mediated phosphorylation. Mol Cell Biol, 26:1806–1816. 2006.
280.
NiniL, WaheedAA, PanickerLM, CzapigaM, ZhangJH, SimondsWF. R7-binding protein targets the G protein beta 5/R7-regulator of G protein signaling complex to lipid rafts in neuronal cells and brain. BMC Biochem, 8:18. 2007.
281.
NovgorodovSA, GudzTI. Ceramide and mitochondria in ischemia/reperfusion. J Cardiovasc Pharmacol, 53:198–208. 2009.
282.
O'ReillyMS, BoehmT, ShingY, FukaiN, VasiosG, LaneWS, FlynnE, BirkheadJR, OlsenBR, FolkmanJ. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88:277–285. 1997.
283.
OakleyFD, AbbottD, LiQ, EngelhardtJF. Signaling components of redox active endosomes: the redoxosomes. Antioxid Redox Signal, 11:1313–1333. 2009.
284.
OakleyFD, SmithRL, EngelhardtJF. Lipid rafts and caveolin-1 coordinate interleukin-1beta (IL-1beta)-dependent activation of NFkappaB by controlling endocytosis of Nox2 and IL-1beta receptor 1 from the plasma membrane. J Biol Chem, 284:33255–33264. 2009.
285.
OchsendorfFR. Infection and reactive oxygen species. Andrologia, 30,Suppl 1:81–86. 1998.
286.
OdaniK, KobayashiT, OgawaY, YoshidaS, SeguchiH. ML-7 inhibits exocytosis of superoxide-producing intracellular compartments in human neutrophils stimulated with phorbol myristate acetate in a myosin light chain kinase-independent manner. Histochem Cell Biol, 119:363–370. 2003.
287.
OhKI, KimBK, BanYL, ChoiEY, JungKC, LeeIS, ParkSH. CD99 activates T cells via a costimulatory function that promotes raft association of TCR complex and tyrosine phosphorylation of TCR zeta. Exp Mol Med, 39:176–184. 2007.
288.
OngSL, ZhangY, WhitworthJA. Reactive oxygen species and glucocorticoid-induced hypertension. Clin Exp Pharmacol Physiol, 35:477–482. 2008.
289.
OshikawaJ, UraoN, KimHW, KaplanN, RazviM, McKinneyR, PooleLB, FukaiT, Ushio-FukaiM. Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice. PLoS One, 5:e10189. 2010.
290.
OstromRS, InselPA. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol, 143:235–245. 2004.
291.
OtahalP, AngelisovaP, HrdinkaM, BrdickaT, NovakP, DrbalK, HorejsiV. A new type of membrane raft-like microdomains and their possible involvement in TCR signaling. J Immunol, 184:3689–3696. 2010.
292.
OyagbemiAA, AzeezOI, SabaAB. Interactions between reactive oxygen species and cancer: the roles of natural dietary antioxidants and their molecular mechanisms of action. Asian Pac J Cancer Prev, 10:535–544. 2009.
293.
PaniB, OngHL, LiuX, RauserK, AmbudkarIS, SinghBB. Lipid rafts determine clustering of STIM1 in endoplasmic reticulum-plasma membrane junctions and regulation of store-operated Ca2+ entry (SOCE)J Biol Chem, 283:17333–17340. 2008.
294.
ParaviciniTM, TouyzRM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care, 31,Suppl 2:S170–S180. 2008.
PattersonSI. Posttranslational protein S-palmitoylation and the compartmentalization of signaling molecules in neurons. Biol Res, 35:139–150. 2002.
300.
PelkmansL. Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses. Biochim Biophys Acta, 1746:295–304. 2005.
301.
PelkmansL, BurliT, ZerialM, HeleniusA. Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell, 118:767–780. 2004.
302.
PelkmansL, HeleniusA. Endocytosis via caveolae. Traffic, 3:311–320. 2002.
303.
PelkmansL, KartenbeckJ, HeleniusA. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol, 3:473–483. 2001.
304.
PerroneGG, TanSX, DawesIW. Reactive oxygen species and yeast apoptosis. Biochim Biophys Acta, 1783:1354–1368. 2008.
305.
PerryG, CastellaniRJ, HiraiK, SmithMA. Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease. J Alzheimers Dis, 1:45–55. 1998.
PiccoliC, RiaR, ScrimaR, CelaO, D'AprileA, BoffoliD, FalzettiF, TabilioA, CapitanioN. Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity. J Biol Chem, 280:26467–26476. 2005.
309.
PikeLJ. Lipid rafts: heterogeneity on the high seas. Biochem J, 378:281–292. 2004.
310.
PlowmanSJ, MunckeC, PartonRG, HancockJF. H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proc Natl Acad Sci U S A, 102:15500–15505. 2005.
311.
PlyteS, MajoliniMB, PaciniS, ScarpiniF, BianchiniC, LanfranconeL, PelicciP, BaldariCT. Constitutive activation of the Ras/MAP kinase pathway and enhanced TCR signaling by targeting the Shc adaptor to membrane rafts. Oncogene, 19:1529–1537. 2000.
312.
PollardTD, BorisyGG. Cellular motility driven by assembly and disassembly of actin filaments. Cell, 112:453–465. 2003.
313.
PoteserM, GrazianiA, RoskerC, EderP, DerlerI, KahrH, ZhuMX, RomaninC, GroschnerK. TRPC3 and TRPC4 associate to form a redox-sensitive cation channel. Evidence for expression of native TRPC3-TRPC4 heteromeric channels in endothelial cells. J Biol Chem, 281:13588–13595. 2006.
314.
PralleA, KellerP, FlorinEL, SimonsK, HorberJK. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J Cell Biol, 148:997–1008. 2000.
315.
PritchardKA, AckermanAW, OuJ, CurtisM, SmalleyDM, FontanaJT, StemermanMB, SessaWC. Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1. Free Radic Biol Med, 33:52–62. 2002.
316.
PudduP, PudduGM, CraveroE, RosatiM, MuscariA. The molecular sources of reactive oxygen species in hypertension. Blood Press, 17:70–77. 2008.
317.
QinXS, TsukaguchiH, ShonoA, YamamotoA, KuriharaH, DoiT. Phosphorylation of nephrin triggers its internalization by raft-mediated endocytosis. J Am Soc Nephrol, 20:2534–2545. 2009.
318.
QiuH, EdmundsT, Baker-MalcolmJ, KareyKP, EstesS, SchwarzC, HughesH, Van PattenSM. Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine. J Biol Chem, 278:32744–32752. 2003.
319.
RajagopalanS, KurzS, MunzelT, TarpeyM, FreemanBA, GriendlingKK, HarrisonDG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest, 97:1916–1923. 1996.
320.
Rao MallaR, RaghuH, RaoJS. Regulation of NADPH oxidase (Nox2) by lipid rafts in breast carcinoma cells. Int J Oncol, 37:1483–1493. 2010.
321.
RavetchJV, BollandS. IgG Fc receptors. Annu Rev Immunol, 19:275–290. 2001.
322.
RazaniB, EngelmanJA, WangXB, SchubertW, ZhangXL, MarksCB, MacalusoF, RussellRG, LiM, PestellRG, Di VizioD, HouHJr., KneitzB, LagaudG, ChristGJ, EdelmannW, LisantiMP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem, 276:38121–38138. 2001.
323.
RehnM, PihlajaniemiT. Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc Natl Acad Sci U S A, 91:4234–4238. 1994.
324.
RentschD, BoorerKJ, FrommerWB. Structure and function of plasma membrane amino acid, oligopeptide and sucrose transporters from higher plants. J Membr Biol, 162:177–190. 1998.
325.
ReshMD. Use of analogs and inhibitors to study the functional significance of protein palmitoylation. Methods, 40:191–197. 2006.
326.
RikihisaY. Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum. Vet Parasitol, 167:155–166. 2010.
327.
RiniaHA, de KruijffB. Imaging domains in model membranes with atomic force microscopy. FEBS Lett, 504:194–199. 2001.
328.
RiniaHA, SnelMM, van der EerdenJP, de KruijffB. Visualizing detergent resistant domains in model membranes with atomic force microscopy. FEBS Lett, 501:92–96. 2001.
329.
RiteauB, BarberDF, LongEO. Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med, 198:469–474. 2003.
330.
RodighieroS, De SimoniA, FormentiA. The voltage-dependent nonselective cation current in human red blood cells studied by means of whole-cell and nystatin-perforated patch-clamp techniques. Biochim Biophys Acta, 1660:164–170. 2004.
RossinA, KralR, LounnasN, ChakrabandhuK, MailfertS, MarguetD, HueberAO. Identification of a lysine-rich region of Fas as a raft nanodomain targeting signal necessary for Fas-mediated cell death. Exp Cell Res, 316:1513–1522. 2010.
333.
SaitohS, ZhangC, TuneJD, PotterB, KiyookaT, RogersPA, KnudsonJD, DickGM, SwaffordA, ChilianWM. Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler Thromb Vasc Biol, 26:2614–2621. 2006.
Samhan-AriasAK, Garcia-BereguiainMA, Martin-RomeroFJ, Gutierrez-MerinoC. Clustering of plasma membrane-bound cytochrome b5 reductase within “lipid raft” microdomains of the neuronal plasma membrane. Mol Cell Neurosci, 40:14–26. 2009.
336.
San MartinA, GriendlingKK. Redox control of vascular smooth muscle migration. Antioxid Redox Signal, 12:625–640. 2010.
337.
SasakiH, YamamotoH, TominagaK, MasudaK, KawaiT, Teshima-KondoS, RokutanK. NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts. J Med Invest, 56:33–41. 2009.
338.
SauerH, WartenbergM, HeschelerJ. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem, 11:173–186. 2001.
339.
SayYH, HooperNM. Contamination of nuclear fractions with plasma membrane lipid rafts. Proteomics, 7:1059–1064. 2007.
340.
Scheel-ToellnerD, WangK, AssiLK, WebbPR, CraddockRM, SalmonM, LordJM. Clustering of death receptors in lipid rafts initiates neutrophil spontaneous apoptosis. Biochem Soc Trans, 32:679–681. 2004.
SchengrundCL. Lipid rafts: keys to neurodegeneration. Brain Res Bull, 82:7–17. 2010.
343.
SchillingT, EderC. Importance of lipid rafts for lysophosphatidylcholine-induced caspase-1 activation and reactive oxygen species generation. Cell Immunol, 265:87–90. 2010.
344.
SchlegelA, VolonteD, EngelmanJA, GalbiatiF, MehtaP, ZhangXL, SchererPE, LisantiMP. Crowded little caves: structure and function of caveolae. Cell Signal, 10:457–463. 1998.
345.
SchmitzG, GrandlM. Role of redox regulation and lipid rafts in macrophages during Ox-LDL-mediated foam cell formation. Antioxid Redox Signal, 9:1499–1518. 2007.
346.
SenguptaP, BairdB, HolowkaD. Lipid rafts, fluid/fluid phase separation, and their relevance to plasma membrane structure and function. Semin Cell Dev Biol, 18:583–590. 2007.
347.
ShaoD, SegalAW, DekkerLV. Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett, 550:101–106. 2003.
348.
SharmaDK, BrownJC, ChoudhuryA, PetersonTE, HolickyE, MarksDL, SimariR, PartonRG, PaganoRE. Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol. Mol Biol Cell, 15:3114–3122. 2004.
349.
SheppardFR, KelherMR, MooreEE, McLaughlinNJ, BanerjeeA, SillimanCC. Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J Leukoc Biol, 78:1025–1042. 2005.
SiafakasAR, WrightLC, SorrellTC, DjordjevicJT. Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase B1 and Cu/Zn superoxide dismutase. Eukaryot Cell, 5:488–498. 2006.
352.
SilvaJP, ProencaF, CoutinhoOP. Protective role of new nitrogen compounds on ROS/RNS-mediated damage to PC12 cells. Free Radic Res, 42:57–69. 2008.
353.
SilviusJR, NabiIR. Fluorescence-quenching and resonance energy transfer studies of lipid microdomains in model and biological membranes. Mol Membr Biol, 23:5–16. 2006.
SimonsK, GruenbergJ. Jamming the endosomal system: lipid rafts and lysosomal storage diseases. Trends Cell Biol, 10:459–462. 2000.
356.
SimonsK, IkonenE. Functional rafts in cell membranes. Nature, 387:569–572. 1997.
357.
SimonsK, IkonenE. How cells handle cholesterol. Science, 290:1721–1726. 2000.
358.
SimonsK, ToomreD. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol, 1:31–39. 2000.
359.
SimonsK, van MeerG. Lipid sorting in epithelial cells. Biochemistry, 27:6197–202. 1988.
360.
SingerSJ. A fluid lipid-globular protein mosaic model of membrane structure. Ann N Y Acad Sci, 195:16–23. 1972.
361.
SingerSJ, NicolsonGL. The fluid mosaic model of the structure of cell membranes. Science, 175:720–31. 1972.
362.
SiowYL, Au-YeungKK, Woo CWO K.Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation. Biochem J, 398:73–82. 2006.
363.
SlaughterN, LauxI, TuX, WhiteleggeJ, ZhuX, EffrosR, BickelP, NelA. The flotillins are integral membrane proteins in lipid rafts that contain TCR-associated signaling components: implications for T-cell activation. Clin Immunol, 108:138–151. 2003.
364.
SmythiesJ. Redox aspects of signaling by catecholamines and their metabolites. Antioxid Redox Signal, 2:575–583. 2000.
365.
SongKS, LiS, OkamotoT, QuilliamLA, SargiacomoM, LisantiMP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem, 271:9690–9697. 1996.
366.
SoriceM, ManganelliV, MatarreseP, TinariA, MisasiR, MalorniW, GarofaloT. Cardiolipin-enriched raft-like microdomains are essential activating platforms for apoptotic signals on mitochondria. FEBS Lett, 583:2447–2450. 2009.
367.
SoubiasO, GawrischK. Nuclear magnetic resonance investigation of oriented lipid membranes. Methods Mol Biol, 400:77–88. 2007.
368.
SowaG, PypaertM, SessaWC. Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci U S A, 98:14072–14077. 2001.
369.
StadtmanER. Role of oxidant species in aging. Curr Med Chem, 11:1105–12. 2004.
370.
StanRV. Structure and function of endothelial caveolae. Microsc Res Tech, 57:350–364. 2002.
371.
StancevicB, KolesnickR. Ceramide-rich platforms in transmembrane signaling. FEBS Lett, 584:1728–1740. 2010.
372.
SteinbauerB, MehnertT, BeyerK. Hydration and lateral organization in phospholipid bilayers containing sphingomyelin: a 2H-NMR study. Biophys J, 85:1013–1024. 2003.
373.
StuvenE, PoratA, ShimronF, FassE, KaloyanovaD, BruggerB, WielandFT, ElazarZ, HelmsJB. Intra-Golgi protein transport depends on a cholesterol balance in the lipid membrane. J Biol Chem, 278:53112–53122. 2003.
374.
SumimotoH, MiyanoK, TakeyaR. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun, 338:677–686. 2005.
375.
SunG, XuX, WangY, ShenX, ChenZ, YangJ. Mycoplasma pneumoniae infection induces reactive oxygen species and DNA damage in A549 human lung carcinoma cells. Infect Immun, 76:4405–4413. 2008.
376.
SuzukiKG, FujiwaraTK, SanematsuF, IinoR, EdidinM, KusumiA. GPI-anchored receptor clusters transiently recruit Lyn and G alpha for temporary cluster immobilization and Lyn activation: single-molecule tracking study 1. J Cell Biol, 177:717–730. 2007.
SzantoI, Rubbia-BrandtL, KissP, StegerK, BanfiB, KovariE, HerrmannF, HadengueA, KrauseKH. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol, 207:164–176. 2005.
379.
SzocsK. Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen Physiol Biophys, 23:265–295. 2004.
380.
SzokeE, BorzseiR, TothDM, LenglO, HelyesZ, SandorZ, SzolcsanyiJ. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line. Eur J Pharmacol, 628:67–74. 2010.
381.
TangXL, TakanoH, RizviA, TurrensJF, QiuY, WuWJ, ZhangQ, BolliR. Oxidant species trigger late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol Heart Circ Physiol, 282:H281–H291. 2002.
382.
TaniM, ItoM, IgarashiY. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell Signal, 19:229–237. 2007.
383.
TianW, LiXJ, StullND, MingW, SuhCI, BissonnetteSA, YaffeMB, GrinsteinS, AtkinsonSJ, DinauerMC. Fc{gamma}R-stimulated activation of the NADPH oxidase: phosphoinositide-binding protein p40phox regulates NADPH oxidase activity after enzyme assembly on the phagosome. Blood, 112:3867–3877. 2008.
384.
Toledo-PereyraLH, Lopez-NeblinaF, ToledoAH. Reactive oxygen species and molecular biology of ischemia/reperfusion. Ann Transplant, 9:81–83. 2004.
385.
TouyzRM. Lipid rafts take center stage in endothelial cell redox signaling by death receptors. Hypertension, 47:16–18. 2006.
386.
UedaN, KaushalGP, ShahSV. Apoptotic mechanisms in acute renal failure. Am J Med, 108:403–415. 2000.
387.
UenoN, TakeyaR, MiyanoK, KikuchiH, SumimotoH. The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators. J Biol Chem, 280:23328–23339. 2005.
388.
Ushio-FukaiM. Localizing NADPH oxidase-derived ROS. Sci STKE, 2006:re8. 2006.
389.
Ushio-FukaiM. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal, 11:1289–1299. 2009.
390.
Ushio-FukaiM, AlexanderRW. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem, 264:85–97. 2004.
391.
Ushio-FukaiM, HilenskiL, SantanamN, BeckerPL, MaY, GriendlingKK, AlexanderRW. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem, 276:48269–48275. 2001.
392.
UtermohlenO, HerzJ, SchrammM, KronkeM. Fusogenicity of membranes: the impact of acid sphingomyelinase on innate immune responses. Immunobiology, 213:307–314. 2008.
393.
ValensinS, PaccaniSR, UlivieriC, MercatiD, PaciniS, PatrussiL, HirstT, LupettiP, BaldariCT. F-actin dynamics control segregation of the TCR signaling cascade to clustered lipid rafts. Eur J Immunol, 32:435–446. 2002.
394.
van MeerG, SimonsK. Lipid polarity and sorting in epithelial cells. J Cell Biochem, 36:51–58. 1988.
395.
Van WartHE, Birkedal-HansenH. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A, 87:5578–5582. 1990.
396.
van ZantenTS, CambiA, KoopmanM, JoostenB, FigdorCG, Garcia-ParajoMF. Hotspots of GPI-anchored proteins and integrin nanoclusters function as nucleation sites for cell adhesion. Proc Natl Acad Sci U S A, 106:18557–18562. 2009.
397.
VetrivelKS, ChengH, LinW, SakuraiT, LiT, NukinaN, WongPC, XuH, ThinakaranG. Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem, 279:44945–44954. 2004.
398.
VilhardtF, van DeursB. The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J, 23:739–748. 2004.
WangHD, JohnsDG, XuS, CohenRA. Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II. Am J Physiol Heart Circ Physiol, 282:H1697–702. 2002.
401.
WangL, Sapuri-ButtiAR, AungHH, ParikhAN, RutledgeJC. Triglyceride-rich lipoprotein lipolysis increases aggregation of endothelial cell membrane microdomains and produces reactive oxygen species. Am J Physiol Heart Circ Physiol, 295:H237–H244. 2008.
402.
WangT, GuJ, WuPF, WangF, XiongZ, YangYJ, WuWN, DongLD, ChenJG. Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation. Free Radic Biol Med, 47:229–240. 2009.
403.
WangX, TianQB, OkanoA, SakagamiH, MoonIS, KondoH, EndoS, SuzukiT. BAALC 1–6-8 protein is targeted to postsynaptic lipid rafts by its N-terminal myristoylation and palmitoylation, and interacts with alpha, but not beta, subunit of Ca/calmodulin-dependent protein kinase II. J Neurochem, 92:647–659. 2005.
404.
WangYX, ZhengYM. ROS-dependent signaling mechanisms for hypoxic Ca(2+) responses in pulmonary artery myocytes. Antioxid Redox Signal, 12:611–623. 2010.
405.
WatanabeM, WakeH, MoorhouseAJ, NabekuraJ. Clustering of neuronal K+-Cl- cotransporters in lipid rafts by tyrosine phosphorylation. J Biol Chem, 284:27980–27988. 2009.
406.
WaughMG, MinogueS, AndersonJS, dos SantosM, HsuanJJ. Signalling and non-caveolar rafts. Biochem Soc Trans, 29:509–511. 2001.
407.
WeaverAK, OlsenML, McFerrinMB, SontheimerH. BK channels are linked to inositol 1,4,5-triphosphate receptors via lipid rafts: a novel mechanism for coupling [Ca(2+)](i) to ion channel activation. J Biol Chem, 282:31558–31568. 2007.
408.
WeiXF, ZhouQG, HouFF, LiuBY, LiangM. Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Renal Physiol, 296:F427–F437. 2009.
Whaley-ConnellA, HabibiJ, NistalaR, CooperSA, KaruparthiPR, HaydenMR, RehmerN, DeMarcoVG, AndresenBT, WeiY, FerrarioC, SowersJR. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Hypertension, 51:474–480. 2008.
412.
WhiteBH, SidhuA. Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: a mechanism for defective dopamine D1A receptor/G-protein coupling. J Hypertens, 16:1659–1665. 1998.
413.
WolfG. Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis. Antioxid Redox Signal, 7:1337–1345. 2005.
414.
WolinMS. Subcellular localization of Nox-containing oxidases provides unique insight into their role in vascular oxidant signaling. Arterioscler Thromb Vasc Biol, 24:625–627. 2004.
415.
WolinMS, AhmadM, GaoQ, GupteSA. Cytosolic NAD(P)H regulation of redox signaling and vascular oxygen sensing. Antioxid Redox Signal, 9:671–678. 2007.
416.
WolinMS, AhmadM, GupteSA. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol, 289:L159–L173. 2005.
417.
WolinMS, AhmadM, GupteSA. The sources of oxidative stress in the vessel wall. Kidney Int, 67:1659–1661. 2005.
418.
WoudenbergJ, RembaczKP, van den HeuvelFA, Woudenberg-VrenkenTE, Buist-HomanM, GeukenM, HoekstraM, DeelmanLE, EnrichC, HenningRH, MoshageH, FaberKN. Caveolin-1 is enriched in the peroxisomal membrane of rat hepatocytes. Hepatology, 51:1744–1753. 2010.
419.
WuH, MahmoodA, LuD, JiangH, XiongY, ZhouD, ChoppM. Attenuation of astrogliosis and modulation of endothelial growth factor receptor in lipid rafts by simvastatin after traumatic brain injury. J Neurosurg, 113:591–597. 2010.
YangB, RizzoV. TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol, 292:H954–H962. 2007.
424.
YangZ, AsicoLD, YuP, WangZ, JonesJE, EscanoCS, WangX, QuinnMT, SibleyDR, RomeroGG, FelderRA, JosePA. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol, 290:R96–R104. 2006.
425.
YaoY, HongS, ZhouH, YuanT, ZengR, LiaoK. The differential protein and lipid compositions of noncaveolar lipid microdomains and caveolae. Cell Res, 19:497–506. 2009.
426.
YaqoobP. The nutritional significance of lipid rafts. Annu Rev Nutr, 29:257–282. 2009.
427.
YasunariK, KohnoM, KanoH, MinamiM, YoshikawaJ. Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors. Circulation, 101:2302–2308. 2000.
428.
YiF, ChenQZ, JinS, LiPL. Mechanism of homocysteine-induced Rac1/NADPH oxidase activation in mesangial cells: role of guanine nucleotide exchange factor Vav2. Cell Physiol Biochem, 20:909–918. 2007.
YiF, JinS, ZhangF, XiaM, BaoJX, HuJ, PoklisJL, LiPL. Formation of lipid raft redox signalling platforms in glomerular endothelial cells: an early event of homocysteine-induced glomerular injury. J Cell Mol Med, 13:3303–3314. 2009.
431.
YiF, XiaM, LiN, ZhangC, TangL, LiPL. Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats. Hypertension, 53:90–96. 2009.
432.
YiF, ZhangAY, JanschaJL, LiPL, ZouAP. Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney Int, 66:1977–1987. 2004.
433.
YiXY, LiVX, ZhangF, YiF, MatsonDR, JiangMT, LiPL. Characteristics and actions of NAD(P)H oxidase on the sarcoplasmic reticulum of coronary artery smooth muscle. Am J Physiol Heart Circ Physiol, 290:H1136–H1144. 2006.
434.
YinT, SandhuG, WolfgangCD, BurrierA, WebbRL, RigelDF, HaiT, WhelanJ. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem, 272:19943–19950. 1997.
435.
YingM, GrimmerS, IversenTG, Van DeursB, SandvigK. Cholesterol loading induces a block in the exit of VSVG from the TGN. Traffic, 4:772–784. 2003.
436.
YoungRM, ZhengX, HolowkaD, BairdB. Reconstitution of regulated phosphorylation of FcepsilonRI by a lipid raft-excluded protein-tyrosine phosphatase. J Biol Chem, 280:1230–1235. 2005.
YuanT, HongS, YaoY, LiaoK. Glut-4 is translocated to both caveolae and non-caveolar lipid rafts, but is partially internalized through caveolae in insulin-stimulated adipocytes. Cell Res, 17:772–782. 2007.
439.
ZabrockiP, BastiaensI, DelayC, BammensT, GhillebertR, PellensK, DeVirgilio C, Van LeuvenF, WinderickxJ. Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson. Biochim Biophys Acta, 1783:1767–1780. 2008.
440.
ZengC, VillarVA, YuP, ZhouL, JosePA. Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens, 31:156–178. 2009.
ZhangAY, TeggatzEG, ZouAP, CampbellWB, LiPL. Endostatin uncouples NO and Ca2+ response to bradykinin through enhanced O2*- production in the intact coronary endothelium. Am J Physiol Heart Circ Physiol, 288:H686–H694. 2005.
443.
ZhangAY, YiF, JinS, XiaM, ChenQZ, GulbinsE, LiPL. Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal, 9:817–828. 2007.
ZhangF, ZhangG, ZhangAY, KoeberlMJ, WallanderE, LiPL. Production of NAADP and its role in Ca2+ mobilization associated with lysosomes in coronary arterial myocytes. Am J Physiol Heart Circ Physiol, 291:H274–H282. 2006.
448.
ZhangG, ZhangF, MuhR, YiF, ChalupskyK, CaiH, LiPL. Autocrine/paracrine pattern of superoxide production through NAD(P)H oxidase in coronary arterial myocytes. Am J Physiol Heart Circ Physiol, 292:H483–H495. 2007.
ZhengL, McQuawCM, EwingAG, WinogradN. Sphingomyelin/phosphatidylcholine and cholesterol interactions studied by imaging mass spectrometry. J Am Chem Soc, 129:15730–15731. 2007.
451.
ZhengYZ, BergKB, FosterLJ. Mitochondria do not contain lipid rafts, and lipid rafts do not contain mitochondrial proteins. J Lipid Res, 50:988–998. 2009.
452.
ZuoL, Ushio-FukaiM, HilenskiLL, AlexanderRW. Microtubules regulate angiotensin II type 1 receptor and Rac1 localization in caveolae/lipid rafts: role in redox signaling. Arterioscler Thromb Vasc Biol, 24:1223–1228. 2004.
453.
ZuoL, Ushio-FukaiM, IkedaS, HilenskiL, PatrushevN, AlexanderRW. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol, 25:1824–1830. 2005.
454.
ZurzoloC, van't HofW, van MeerG, Rodriguez-BoulanE. VIP21/caveolin, glycosphingolipid clusters and the sorting of glycosylphosphatidylinositol-anchored proteins in epithelial cells. EMBO J, 13:42–53. 1994.
